LENZ Therapeutics, Inc.
7.00%
1,967,275
1815776
52635N103
Jun 19, 2025
Jun 24, 2025, 04:21 PM
Reporting Persons (9)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | Partnership | 7.00% | 1,967,275 | 1,967,275 | 0 |
| Versant Ventures VI GP, L.P. | Partnership | 7.00% | 1,967,275 | 0 | 1,967,275 |
| Versant Ventures VI GP-GP, LLC | Other | 7.00% | 1,967,275 | 0 | 1,967,275 |
| Versant Ventures VII GP-GP, LLC | Other | 4.00% | 1,118,446 | 0 | 1,118,446 |
| Versant Venture Capital VII, L.P. | Partnership | 4.00% | 1,118,446 | 1,118,446 | 0 |
| Versant Ventures VII GP, L.P. | Partnership | 4.00% | 1,118,446 | 0 | 1,118,446 |
| Versant Vantage II, L.P. | Partnership | 3.00% | 842,162 | 842,162 | 0 |
| Versant Vantage II GP, L.P. | Partnership | 3.00% | 842,162 | 0 | 842,162 |
| Versant Vantage II GP-GP, LLC | Other | 3.00% | 842,162 | 0 | 842,162 |
Disclosure Items (2)
Common Stock, par value $0.00001 per share
LENZ Therapeutics, Inc.
201 Lomas Santa Fe Dr., Solana Beach, CA, 92075
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
On June 18, 2025, Versant VII sold 100,000 shares of Common Stock at a price per share of $29.95 for aggregate proceeds of approximately $2,995,000.00 On June 20, 2025, Versant VII sold 100,877 shares of Common Stock at a price per share of $30.35 for aggregate proceeds of approximately $3,061,616.95. On June 20, 2025, Versant VI sold 133,924 shares of Common Stock at a price per share of $30.25 for aggregate proceeds of approximately $4,051,201.00.